Your browser doesn't support javascript.
loading
Fosinopril and hydrochlorothiazide combination versus individual components: lack of a pharmacokinetic interaction.
Uderman, H D; Much, D R; Brennan, J; Delaney, C L; Morgenthien, E A; Weaver, J; Stouffer, B C; Chang, S Y; VanHarken, D; Liao, W.
Affiliation
  • Uderman HD; Bristol-Myers Squibb Clinical Research Unit, Hamilton, NJ 08690, USA.
Ann Pharmacother ; 33(5): 525-30, 1999 May.
Article in En | MEDLINE | ID: mdl-10369612
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Fosinopril / Sodium Chloride Symporter Inhibitors / Hydrochlorothiazide Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Male Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Fosinopril / Sodium Chloride Symporter Inhibitors / Hydrochlorothiazide Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Male Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos